Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jamal Benhamida
Colorectal Carcinomas Containing Hypermethylated MLH1 Promoter and Wild Type BRAF/KRAS Are Enriched for Targetable Kinase Fusions
Cancer Research
Cancer Research
Oncology
Validation of Mitotic Cell Quantification via Microscopy and Multiple Whole-Slide Scanners
Diagnostic Pathology
Forensic Medicine
Medicine
Pathology
Histology
Related publications
FOLFIRI Plus Panitumumab in the Treatment of Wild-Type KRAS and Wild-Type NRAS Metastatic Colorectal Cancer
World Journal of Surgical Oncology
Surgery
Oncology
Cetuximab Alone or With Irinotecan for Resistant KRAS-, NRAS-, BRAF- And PIK3CA- Wild-Type Metastatic Colorectal Cancer: The AGITG Randomised Phase II ICECREAM Study
Clinical Colorectal Cancer
Oncology
Gastroenterology
Mutation Pattern of KRAS and BRAF Oncogenes in Colorectal Cancer Patients
Neoplasma
Cancer Research
Relative Expression of Wild-Type and Activated Ki-Ras2 Oncogene in Colorectal Carcinomas
International Journal of Oncology
Cancer Research
Oncology
Inhibition of EGFR, HER2, and HER3 Signalling in Patients With Colorectal Cancer Wild-Type for BRAF, PIK3CA, KRAS , and NRAS (FOCUS4-D): A Phase 2–3 Randomised Trial
Lancet Gastroenterology and Hepatology, The
Hepatology
Gastroenterology
MLH1-silenced and Non-Silenced Subgroups of Hypermutated Colorectal Carcinomas Have Distinct Mutational Landscapes
Journal of Pathology
Forensic Medicine
Pathology
Colorectal Mixed Adenoneuroendocrine Carcinomas and Neuroendocrine Carcinomas Are Genetically Closely Related to Colorectal Adenocarcinomas
Modern Pathology
Forensic Medicine
Pathology
Molecular Pathological Epidemiology of Colorectal Cancer in Chinese Patients With KRAS and BRAF Mutations
Oncotarget
Oncology
Combination PI3K/MEK Inhibition Promotes Tumor Apoptosis and Regression in PIK3CA Wild-Type, KRAS Mutant Colorectal Cancer
Cancer Letters
Cancer Research
Oncology
